Clinical Trials Directory

Trials / Unknown

UnknownNCT06259487

Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.

Study on the Impact of Coordinated Immunizations Against RSV and Influenza on the Prognosis in Patients With Chronic Heart Failure.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
250 (estimated)
Sponsor
Wroclaw Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This prospective, single-centre, open-label, randomized study aims to determine whether coordinated care in administering protective vaccinations (against Respiratory Syncytial Virus (RSV) and influenza) impacts the prognosis of patients with chronic heart failure. The main question it aims to answer is: • Does coordinated care through vaccinations improve the prognosis of patients with chronic heart failure?

Detailed description

The study aims to determine whether coordinated care in the form of administering protective vaccinations affects the prognosis of patients with chronic heart failure. The study will involve analyzing epidemiological data for each participant, followed by randomization into two treatment paths: receiving vaccinations against Respiratory Syncytial Virus (RSV) and influenza provided by the research team (i.e., during cardiology visits) versus following standard recommendations for protective vaccinations (i.e., receiving vaccinations at vaccination points). All vaccinations will be administered using vaccines registered with the appropriate authorities and approved for use in the EU and Poland.

Conditions

Interventions

TypeNameDescription
BIOLOGICALCoordinated VaccinationCoordinated Vaccination against Respiratory Syncytial Virus (RSV) and influenza provided by the research team (i.e., during cardiology visits)
BEHAVIORALFollowing recommendationsGuidance on following the standard recommendations for protective vaccinations (i.e., receiving vaccinations at vaccination points).

Timeline

Start date
2023-09-15
Primary completion
2024-06-30
Completion
2024-07-30
First posted
2024-02-14
Last updated
2024-02-14

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT06259487. Inclusion in this directory is not an endorsement.